Page last updated: 2024-11-07

inositol-1,3,4,6-tetrakisphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Inositol-1,3,4,6-tetrakisphosphate (InsP4) is a signaling molecule involved in various cellular processes, including calcium homeostasis, membrane trafficking, and cell growth. It is a phosphorylated derivative of inositol, a sugar alcohol that is a key component of cell membranes. InsP4 is synthesized from inositol-1,4,5-trisphosphate (InsP3) by the action of specific kinases. Its synthesis is tightly regulated and can be influenced by various stimuli, such as hormones and growth factors. InsP4 is known to interact with and regulate the activity of a variety of proteins, including ion channels, protein kinases, and phosphatases. It is thought to play a role in the regulation of intracellular calcium levels by affecting the activity of calcium channels and pumps. Additionally, InsP4 has been implicated in the regulation of membrane trafficking, particularly in processes like endocytosis and exocytosis. InsP4 is a crucial signaling molecule in cell signaling pathways, and its dysregulation has been linked to various diseases, including cancer and neurological disorders. This makes it a target for drug development. Research on InsP4 focuses on understanding its precise role in various cellular processes, its interactions with specific proteins, and its potential therapeutic applications. The study of InsP4 is essential for gaining insights into cell signaling pathways, potential drug targets, and the development of new therapies for related diseases.'

inositol-1,3,4,6-tetrakisphosphate: for cpd without numerical locants of phosphate groups, index INOSITOL PHOSPHATES [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

myo-inositol 1,3,4,6-tetrakisphosphate : A myo-inositol tetrakisphosphate having the phosphate groups placed at the 1-, 3-, 4- and 6-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID121969
CHEBI ID16155
SCHEMBL ID8441712
MeSH IDM0217735

Synonyms (26)

Synonym
CHEBI:16155 ,
110298-84-5
inositol-1,3,4,6-tetrakisphosphate
myo-inositol-1,3,4,6-tetrakisphosphate
ins-1,3,4,6-p4
myo-inositol 1,3,4,6-tetrakisphosphate
inositol-1,3,4,6-tetraphosphate
myo-inositol 1,3,4,6-tetrakis(dihydrogen phosphate)
inositol 1,3,4,6-tetrakisphosphate
C04477
ins(1,3,4,6)p4
d-myo-inositol 1,3,4,6-tetrakisphosphate
1d-myo-inositol 1,3,4,6-tetrakisphosphate
DB04300
(1s,3r,4r,6s)-1,3,4,6-tetrapkisphosphate
i4p ,
chiro-inositol 1,3,4,6-tetrakisphosphate
myo-inositol, 1,3,4,6-tetrakis(dihydrogen phosphate)
SCHEMBL8441712
d-myo-inositol 1,3,4,5-tetrakis-*phosphate potass
d-myo-inositol-1,3,4,5-tetrakisphosphate octapotassium salt
(1r,2r,3r,4s,5s,6s)-3,6-dihydroxycyclohexane-1,2,4,5-tetrayl tetrakis[dihydrogen (phosphate)]
Q27095123
[(1s,3r,4r,6s)-2,5-dihydroxy-3,4,6-triphosphonooxycyclohexyl] dihydrogen phosphate
(2,5-dihydroxy-3,4,6-triphosphonooxy-cyclohexoxy)phosphonic acid
DTXSID901317184
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (16.00)18.7374
1990's17 (68.00)18.2507
2000's4 (16.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.52 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]